Assembly Biosciences Inc (V7B)

Currency in EUR
15.950
-0.650(-3.92%)
Delayed Data·
V7B Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
V7B is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
15.95015.950
52 wk Range
6.98017.950
Key Statistics
Bid/Ask
15.95 / 16.15
Prev. Close
16.6
Open
15.95
Day's Range
15.95-15.95
52 wk Range
6.98-17.95
Volume
-
Average Volume (3m)
648
1-Year Change
22.51%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
V7B Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Assembly Biosciences Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Neutral

Assembly Biosciences Inc Company Profile

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5336 and ABI-1179, which are in Phase 1a/1b clinical studies for recurrent genital herpes; ABI-4334, a capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus that is in Phase 1b clinical study; and ABI-6250, an orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical study. The company also develops ABI-7423, an oral broad-spectrum non-nucleoside polymerase inhibitor that targets transplant-related herpesviruses. It has an option, license, and collaboration agreement with Gilead Sciences, Inc. for the research and development of virology therapies. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.

Compare V7B to Peers and Sector

Metrics to compare
V7B
Peers
Sector
Relationship
P/E Ratio
−3.5x−1.7x−0.5x
PEG Ratio
−0.09−0.010.00
Price/Book
5.2x2.4x2.6x
Price / LTM Sales
4.4x40.0x3.2x
Upside (Analyst Target)
-231.5%42.0%
Fair Value Upside
Unlock29.9%6.6%Unlock

Earnings

Latest Release
May 08, 2025
EPS / Forecast
-1.17 / --
Revenue / Forecast
9.42M / --
EPS Revisions
Last 90 days

V7B Income Statement

People Also Watch

109.38
CRDO
+1.32%
224.08
LEU
-6.40%
23.22
OUST
-10.49%
53.090
ASTS
-2.08%
193.90
ALL
+0.99%

FAQ

What Stock Exchange Does Assembly Biosciences Inc Trade On?

Assembly Biosciences Inc is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for Assembly Biosciences Inc?

The stock symbol for Assembly Biosciences Inc is "V7B."

What Is the Assembly Biosciences Inc Market Cap?

As of today, Assembly Biosciences Inc market cap is 121.22M.

What Is Assembly Biosciences Inc's Earnings Per Share (TTM)?

The Assembly Biosciences Inc EPS (TTM) is -6.13.

From a Technical Analysis Perspective, Is V7B a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Assembly Biosciences Inc Stock Split?

Assembly Biosciences Inc has split 2 times.

How Many Employees Does Assembly Biosciences Inc Have?

Assembly Biosciences Inc has 73 employees.

What is the current trading status of Assembly Biosciences Inc (V7B)?

As of 30 Jul 2025, Assembly Biosciences Inc (V7B) is trading at a price of 15.95, with a previous close of 16.60. The stock has fluctuated within a day range of 15.95 to 15.95, while its 52-week range spans from 6.98 to 17.95.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.